BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24344904)

  • 1. Plasma elevation of vascular endothelial growth factor leads to the reduction of mouse hematopoietic and mesenchymal stem/progenitor cells in the bone marrow.
    Tashiro K; Nonaka A; Hirata N; Yamaguchi T; Mizuguchi H; Kawabata K
    Stem Cells Dev; 2014 Sep; 23(18):2202-10. PubMed ID: 24344904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute exercise mobilizes hematopoietic stem and progenitor cells and alters the mesenchymal stromal cell secretome.
    Emmons R; Niemiro GM; Owolabi O; De Lisio M
    J Appl Physiol (1985); 2016 Mar; 120(6):624-32. PubMed ID: 26744505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic progenitor cell mobilization results in hypoxia with increased hypoxia-inducible transcription factor-1 alpha and vascular endothelial growth factor A in bone marrow.
    Lévesque JP; Winkler IG; Hendy J; Williams B; Helwani F; Barbier V; Nowlan B; Nilsson SK
    Stem Cells; 2007 Aug; 25(8):1954-65. PubMed ID: 17478585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
    Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes impairs mobilization of mouse bone marrow-derived Lin(-)/VEGF-R2(+) progenitor cells.
    Barthelmes D; Irhimeh MR; Gillies MC; Karimipour M; Zhou M; Zhu L; Shen WY
    Blood Cells Mol Dis; 2013 Oct; 51(3):163-73. PubMed ID: 23714230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic corticosterone oscillations regulate murine hematopoietic stem/progenitor cell proliferation and CXCL12 expression by bone marrow stromal progenitors.
    Kollet O; Vagima Y; D'Uva G; Golan K; Canaani J; Itkin T; Gur-Cohen S; Kalinkovich A; Caglio G; Medaglia C; Ludin A; Lapid K; Shezen E; Neufeld-Cohen A; Varol D; Chen A; Lapidot T
    Leukemia; 2013 Oct; 27(10):2006-15. PubMed ID: 23680895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pivotal role of bone remodeling in granulocyte colony stimulating factor induced hematopoietic stem/progenitor cells mobilization.
    Li S; Zhai Q; Zou D; Meng H; Xie Z; Li C; Wang Y; Qi J; Cheng T; Qiu L
    J Cell Physiol; 2013 May; 228(5):1002-9. PubMed ID: 23042582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stromal cells induce a permissive state in the bone marrow that enhances G-CSF-induced hematopoietic stem cell mobilization in mice.
    de Kruijf EFM; Zuijderduijn R; Stip MC; Fibbe WE; van Pel M
    Exp Hematol; 2018 Aug; 64():59-70.e2. PubMed ID: 29775645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF7 supports hematopoietic stem and progenitor cells and niche-dependent myeloblastoma cells via autocrine action on bone marrow stromal cells in vitro.
    Ishino R; Minami K; Tanaka S; Nagai M; Matsui K; Hasegawa N; Roeder RG; Asano S; Ito M
    Biochem Biophys Res Commun; 2013 Oct; 440(1):125-31. PubMed ID: 24051090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes impairs hematopoietic stem cell mobilization by altering niche function.
    Ferraro F; Lymperi S; Méndez-Ferrer S; Saez B; Spencer JA; Yeap BY; Masselli E; Graiani G; Prezioso L; Rizzini EL; Mangoni M; Rizzoli V; Sykes SM; Lin CP; Frenette PS; Quaini F; Scadden DT
    Sci Transl Med; 2011 Oct; 3(104):104ra101. PubMed ID: 21998408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of stromal cell-derived factor and its receptor-CXCR4 in G-CSF-induced hematopoietic stem cell mobilization].
    Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):98-102. PubMed ID: 17650669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-CSF treatment of healthy pediatric donors affects their hematopoietic microenvironment through changes in bone marrow plasma cytokines and stromal cells.
    Aerts-Kaya F; Kilic E; Köse S; Aydin G; Cagnan I; Kuskonmaz B; Uckan-Cetinkaya D
    Cytokine; 2021 Mar; 139():155407. PubMed ID: 33383380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte colony-stimulating factor and an RARalpha specific agonist, VTP195183, synergize to enhance the mobilization of hematopoietic progenitor cells.
    Herbert KE; Walkley CR; Winkler IG; Hendy J; Olsen GH; Yuan YD; Chandraratna RA; Prince HM; Lévesque JP; Purton LE
    Transplantation; 2007 Feb; 83(4):375-84. PubMed ID: 17318068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization.
    Jin F; Zhai Q; Qiu L; Meng H; Zou D; Wang Y; Li Q; Yu Z; Han J; Li Q; Zhou B
    Bone Marrow Transplant; 2008 Nov; 42(9):581-8. PubMed ID: 18679363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel anti-inflammatory function of human galectin-1: inhibition of hematopoietic progenitor cell mobilization.
    Kiss J; Kunstár A; Fajka-Boja R; Dudics V; Tóvári J; Légrádi A; Monostori E; Uher F
    Exp Hematol; 2007 Feb; 35(2):305-13. PubMed ID: 17258079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow.
    Ratajczak MZ; Kucia M; Reca R; Majka M; Janowska-Wieczorek A; Ratajczak J
    Leukemia; 2004 Jan; 18(1):29-40. PubMed ID: 14586476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow.
    Brunner S; Zaruba MM; Huber B; David R; Vallaster M; Assmann G; Mueller-Hoecker J; Franz WM
    Exp Hematol; 2008 Sep; 36(9):1157-66. PubMed ID: 18504066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal hematopoietic stem cell homing is controlled by VEGF regulating the integrity and oxidative status of the stromal-vascular bone marrow niches.
    Mesnieres M; Böhm AM; Peredo N; Trompet D; Valle-Tenney R; Bajaj M; Corthout N; Nefyodova E; Cardoen R; Baatsen P; Munck S; Nagy A; Haigh JJ; Khurana S; Verfaillie CM; Maes C
    Cell Rep; 2021 Aug; 36(8):109618. PubMed ID: 34433017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that a lipolytic enzyme--hematopoietic-specific phospholipase C-β2--promotes mobilization of hematopoietic stem cells by decreasing their lipid raft-mediated bone marrow retention and increasing the promobilizing effects of granulocytes.
    Adamiak M; Poniewierska-Baran A; Borkowska S; Schneider G; Abdelbaset-Ismail A; Suszynska M; Abdel-Latif A; Kucia M; Ratajczak J; Ratajczak MZ
    Leukemia; 2016 Apr; 30(4):919-28. PubMed ID: 26582648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of the CXC chemokine receptor 4/stromal cell-derived factor 1 pathway enhances myocardial neovascularization, cardiomyocyte survival, and functional recovery after myocardial infarction.
    Bonaros N; Sondermeijer H; Wiedemann D; Schlechta B; Schachner T; Schuster M; Seki T; Martens TP; Itescu S; Kocher AA
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):687-96, 696.e1-2. PubMed ID: 21388641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.